Industry Insight
Information, Observation & Analysis
Vaccines Articles
Through continued breakthroughs in vaccine research and technology, scientists are developing new techniques and approaches to address historical illnesses, and updates in policy aren’t far behind.
Healthcare professionals who provide preventive vaccines to patients will be affected in many ways, including an increase in patients, as well as changes in billing and reimbursement.
A new class of quadrivalent flu vaccines may better protect against influenza.
An adjuvanted influenza vaccine to protect the young and elderly may be just around the corner in the U.S.
Imagine a plague that wipes out the entire population of Chicago. Implausible? Without vaccines, that’s the number of people — three million to be specific — who would die each year from vaccine-preventable diseases.
From the eradication of smallpox to the potential development of a preventive vaccine for AIDS, immunization is a lifesaving innovation that has proven to be the most transformative public health achievement of the 20th century.
Traditionally used as a preventive measure against a variety of diseases, vaccines are now being used to diagnose immune-deficient patients, and research is being conducted to use vaccines to treat immune and autoimmune diseases.
The progress made to improve vaccination rates around the world is astounding, made possible through the cooperation and funding of many organizations, but much still needs to be done to decrease or eradicate vaccinepreventable diseases
To secure a federal grant, researchers must navigate a rigorous and long application process. But, when completed properly, those projects deemed most likely to have an impact on the nation’s health do get funded.
New research comparing the new Fluzone High-Dose vaccine and the seasonal flu vaccine sheds light on how ineffective the latter vaccine has been for the elderly.
From identifying the strain to prioritizing high-risk recipients, a look at lessons learned from the development and distribution of the H1N1 vaccine.
Vaccines to treat pre-existing conditions have the potential to radically change medical treatment, and there’s renewed hope that therapeutic vaccines might soon be available to treat various diseases.